Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 185

1.

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group.

N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066.

PMID:
26699169
2.

Beneficial immune effects of myeloid-related proteins in kidney transplant rejection.

Rekers NV, Bajema IM, Mallat MJ, Petersen B, Anholts JD, Swings GM, van Miert PP, Kerkhoff C, Roth J, Popp D, van Groningen MC, Baeten D, Goemaere N, Kraaij MD, Zandbergen M, Heidt S, van Kooten C, de Fijter JW, Claas FH, Eikmans M.

Am J Transplant. 2015 Nov 26. doi: 10.1111/ajt.13634. [Epub ahead of print]

PMID:
26607974
3.

Recent Advances in the Treatment of Immune-Mediated Inflammatory Diseases.

Tas SW, Baeten DL.

Methods Mol Biol. 2016;1371:143-55. doi: 10.1007/978-1-4939-3139-2_9.

PMID:
26530799
4.

Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

Musters A, Tak PP, Baeten DL, Tas SW.

BMJ Case Rep. 2015 Oct 29;2015. pii: bcr2015210513. doi: 10.1136/bcr-2015-210513.

PMID:
26516243
5.

Immunopathology of synovitis: from histology to molecular pathways.

van de Sande MG, Baeten DL.

Rheumatology (Oxford). 2015 Sep 10. pii: kev330. [Epub ahead of print] Review.

PMID:
26359330
6.

Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study.

Baraliakos X, Borah B, Braun J, Baeten D, Laurent D, Sieper J, Emery P, McInnes IB, van Laar JM, Wordsworth P, Wollenhaupt J, Kellner H, Colin L, Vandenhende F, Radford K, Hueber W.

Ann Rheum Dis. 2015 Aug 6. pii: annrheumdis-2015-207544. doi: 10.1136/annrheumdis-2015-207544. [Epub ahead of print]

PMID:
26248638
7.

A psychometric analysis of outcome measures in peripheral spondyloarthritis.

Turina MC, Ramiro S, Baeten DL, Mease P, Paramarta JE, Song IH, Pangan AL, Landewé R.

Ann Rheum Dis. 2015 Aug 5. pii: annrheumdis-2014-207235. doi: 10.1136/annrheumdis-2014-207235. [Epub ahead of print]

8.

Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis.

Vieira-Sousa E, van Duivenvoorde LM, Fonseca JE, Lories RJ, Baeten DL.

Arthritis Rheumatol. 2015 Nov;67(11):2813-27. doi: 10.1002/art.39282. Review. No abstract available.

PMID:
26215401
9.

Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis.

Cañete JD, Celis R, Yeremenko N, Sanmartí R, van Duivenvoorde L, Ramírez J, Blijdorp I, García-Herrero CM, Pablos JL, Baeten DL.

Arthritis Res Ther. 2015 Jul 9;17:173. doi: 10.1186/s13075-015-0688-0.

10.

Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis.

Kerkman PF, Fabre E, van der Voort EI, Zaldumbide A, Rombouts Y, Rispens T, Wolbink G, Hoeben RC, Spits H, Baeten DL, Huizinga TW, Toes RE, Scherer HU.

Ann Rheum Dis. 2015 Jun 1. pii: annrheumdis-2014-207182. doi: 10.1136/annrheumdis-2014-207182. [Epub ahead of print]

PMID:
26034045
11.

Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint.

Yeremenko N, Zwerina K, Rigter G, Pots D, Fonseca JE, Zwerina J, Schett G, Baeten D.

Arthritis Rheumatol. 2015 May;67(8):2071-5. doi: 10.1002/art.39183.

PMID:
25941031
12.

Simultaneous Synchrotron WAXD and Fast Scanning (Chip) Calorimetry: On the (Isothermal) Crystallization of HDPE and PA11 at High Supercoolings and Cooling Rates up to 200 °C s(-1).

Baeten D, Mathot VB, Pijpers TF, Verkinderen O, Portale G, Van Puyvelde P, Goderis B.

Macromol Rapid Commun. 2015 Jun;36(12):1184-91. doi: 10.1002/marc.201500081. Epub 2015 Apr 7.

PMID:
25845310
13.

Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity.

Vogelpoel LT, Baeten DL, de Jong EC, den Dunnen J.

Front Immunol. 2015 Feb 24;6:79. doi: 10.3389/fimmu.2015.00079. eCollection 2015. Review.

14.

Autoimmunity: break-through in the diagnosis and treatment of immune-mediated inflammatory diseases.

Kroese FG, Baeten D, Huizinga TW.

Immunol Lett. 2014 Dec;162(2 Pt B):150-62. doi: 10.1016/j.imlet.2014.10.013. Epub 2014 Oct 19. Review.

PMID:
25455603
15.

Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression.

Angiolilli C, Grabiec AM, Ferguson BS, Ospelt C, Malvar Fernandez B, van Es IE, van Baarsen LG, Gay S, McKinsey TA, Tak PP, Baeten DL, Reedquist KA.

Ann Rheum Dis. 2014 Dec 1. pii: annrheumdis-2014-205635. doi: 10.1136/annrheumdis-2014-205635. [Epub ahead of print]

PMID:
25452308
16.

Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages.

Vogelpoel LT, Hansen IS, Rispens T, Muller FJ, van Capel TM, Turina MC, Vos JB, Baeten DL, Kapsenberg ML, de Jong EC, den Dunnen J.

Nat Commun. 2014 Nov 13;5:5444. doi: 10.1038/ncomms6444.

17.

Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis.

Turina MC, Yeremenko N, Paramarta JE, De Rycke L, Baeten D.

Arthritis Res Ther. 2014 Aug 19;16(4):413. doi: 10.1186/s13075-014-0413-4.

18.

FHL2 regulates the resolution of tissue damage in chronic inflammatory arthritis.

Wixler V, Cromme C, Retser E, Meyer LH, Smyth N, Mühlenberg K, Korb-Pap A, Koers-Wunrau C, Sotsios Y, Bassel-Duby R, Baeten D, Tak PP, Niederreiter B, Redlich K, Bertrand J, Skryabin BV, Ludwig S, Pap T.

Ann Rheum Dis. 2015 Dec;74(12):2216-23. doi: 10.1136/annrheumdis-2013-205061. Epub 2014 Aug 14.

PMID:
25125695
20.

Response to: 'paying attention to enthesitis in early untreated arthritis: MRI for the evaluation of enthesitis', by Zhou et al.

Paramarta JE, Baeten D.

Ann Rheum Dis. 2014 Oct;73(10):e61. doi: 10.1136/annrheumdis-2014-206131. Epub 2014 Jul 18. No abstract available.

PMID:
25038236
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk